Beijing Strong Biotechnologies,Inc. (SHE:300406)
China
· Delayed Price · Currency is CNY 12.65
+0.10 (0.80%)
Mar 10, 2026, 10:45 AM CST
SHE:300406 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 7,339 | 7,797 | 11,206 | 9,611 | 11,674 | 14,737 | Upgrade
|
| Market Cap Growth | -7.59% | -30.42% | 16.60% | -17.67% | -20.79% | 80.62% | Upgrade
|
| Enterprise Value | 7,656 | 7,968 | 11,921 | 10,422 | 12,416 | 14,796 | Upgrade
|
| Last Close Price | 12.55 | 12.51 | 17.70 | 15.11 | 18.18 | 22.83 | Upgrade
|
| PE Ratio | 17.20 | 14.64 | 21.40 | 24.70 | 28.78 | 131.25 | Upgrade
|
| Forward PE | - | 10.80 | 18.21 | 18.45 | 21.43 | 30.51 | Upgrade
|
| PS Ratio | 5.12 | 4.70 | 6.43 | 6.36 | 7.30 | 17.38 | Upgrade
|
| PB Ratio | 1.84 | 1.89 | 3.01 | 2.94 | 4.01 | 4.31 | Upgrade
|
| P/TBV Ratio | 3.22 | 3.24 | 5.63 | 6.27 | 10.35 | 10.14 | Upgrade
|
| P/FCF Ratio | 12.26 | 14.27 | 25.64 | 32.07 | 42.31 | 139.27 | Upgrade
|
| P/OCF Ratio | 11.51 | 12.70 | 19.15 | 24.26 | 34.22 | 119.75 | Upgrade
|
| EV/Sales Ratio | 5.34 | 4.80 | 6.85 | 6.90 | 7.76 | 17.45 | Upgrade
|
| EV/EBITDA Ratio | 13.33 | 11.37 | 18.12 | 18.80 | 21.03 | 75.47 | Upgrade
|
| EV/EBIT Ratio | 15.53 | 12.61 | 19.73 | 20.79 | 22.65 | 89.22 | Upgrade
|
| EV/FCF Ratio | 12.78 | 14.58 | 27.28 | 34.78 | 45.00 | 139.83 | Upgrade
|
| Debt / Equity Ratio | 0.27 | 0.28 | 0.31 | 0.34 | 0.39 | 0.09 | Upgrade
|
| Debt / EBITDA Ratio | 1.86 | 1.66 | 1.72 | 1.98 | 1.90 | 1.53 | Upgrade
|
| Debt / FCF Ratio | 1.78 | 2.14 | 2.60 | 3.68 | 4.08 | 2.84 | Upgrade
|
| Net Debt / Equity Ratio | 0.08 | 0.01 | 0.07 | 0.13 | 0.25 | -0.09 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.56 | 0.05 | 0.39 | 0.79 | 1.24 | -1.54 | Upgrade
|
| Net Debt / FCF Ratio | 0.54 | 0.07 | 0.59 | 1.46 | 2.65 | -2.86 | Upgrade
|
| Asset Turnover | 0.27 | 0.31 | 0.36 | 0.34 | 0.39 | 0.28 | Upgrade
|
| Inventory Turnover | 1.29 | 1.61 | 1.98 | 1.63 | 1.80 | 1.66 | Upgrade
|
| Quick Ratio | 8.69 | 8.31 | 7.01 | 6.01 | 2.38 | 5.99 | Upgrade
|
| Current Ratio | 11.66 | 9.28 | 7.86 | 6.94 | 2.87 | 7.31 | Upgrade
|
| Return on Equity (ROE) | 10.85% | 13.53% | 14.94% | 12.76% | 14.82% | 4.51% | Upgrade
|
| Return on Assets (ROA) | 5.73% | 7.35% | 7.72% | 7.02% | 8.27% | 3.39% | Upgrade
|
| Return on Invested Capital (ROIC) | 10.29% | 13.27% | 13.83% | 11.97% | 14.17% | 5.95% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.70% | 11.90% | 12.40% | 11.60% | 14.80% | 4.50% | Upgrade
|
| Earnings Yield | 5.88% | 6.83% | 4.67% | 4.05% | 3.48% | 0.76% | Upgrade
|
| FCF Yield | 8.16% | 7.01% | 3.90% | 3.12% | 2.36% | 0.72% | Upgrade
|
| Dividend Yield | 3.97% | 3.20% | 1.13% | 0.66% | 0.55% | 0.43% | Upgrade
|
| Payout Ratio | 97.46% | 23.32% | 12.35% | 23.30% | 19.38% | 73.42% | Upgrade
|
| Buyback Yield / Dilution | 1.02% | 0.56% | 3.00% | -4.37% | -7.25% | -9.09% | Upgrade
|
| Total Shareholder Return | 4.99% | 3.76% | 4.13% | -3.71% | -6.70% | -8.66% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.